ESOPHAGEAL SQUAMOUS CELL CARCINOMA (ESCC)
Clinical trials for ESOPHAGEAL SQUAMOUS CELL CARCINOMA (ESCC) explained in plain language.
Never miss a new study
Get alerted when new ESOPHAGEAL SQUAMOUS CELL CARCINOMA (ESCC) trials appear
Sign up with your email to follow new studies for ESOPHAGEAL SQUAMOUS CELL CARCINOMA (ESCC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for esophageal cancer: drug cocktail trial shows promise
Disease control CompletedThis study tested new drug combinations, including pembrolizumab (an immunotherapy), for people with advanced esophageal cancer that had gotten worse after one prior treatment. About 90 participants received different experimental treatments to see if they were safe and could shr…
Matched conditions: ESOPHAGEAL SQUAMOUS CELL CARCINOMA (ESCC)
Phase: PHASE1, PHASE2 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated May 15, 2026 11:57 UTC
-
New drug combo shows promise in slowing esophageal cancer
Disease control CompletedThis study tested whether adding the drug tislelizumab to standard chemoradiotherapy helps people with localized esophageal squamous cell carcinoma. 370 participants received either tislelizumab or a placebo alongside their cancer treatment. The main goal was to see if the drug c…
Matched conditions: ESOPHAGEAL SQUAMOUS CELL CARCINOMA (ESCC)
Phase: PHASE3 • Sponsor: BeiGene • Aim: Disease control
Last updated May 13, 2026 16:02 UTC
-
New combo treatment matches standard for esophageal cancer survival
Knowledge-focused CompletedThis study looked at 200 people with advanced esophageal cancer to see if a newer treatment (immunotherapy plus chemotherapy) works as well as the standard treatment (chemotherapy plus radiation) before surgery. Both treatments led to similar long-term survival rates. The newer t…
Matched conditions: ESOPHAGEAL SQUAMOUS CELL CARCINOMA (ESCC)
Phase: NA • Sponsor: Yongtao Han • Aim: Knowledge-focused
Last updated May 15, 2026 11:55 UTC